baber/WOPTO huggingface dataset:
Patent CA-2507538-A1 (CA)
Title: Apparatus for inhibiting fines carryover
Inventor: BROCK SIMON THOMAS HENRY
IPC: B01D24/04
Filed: 2003-11-28
Abstract: Apparatus for inhibiting fines carryover in the form of a settlement tank comprising: a filter which divides the tank into upper and lower portions; a fluid inlet in the lower portion for admitting into the tank a fluid with entrained solids; and a fluid outlet in the upper portion through which filtered fluid can leave the tank. The filter comprises filter media supported on a permeable wall, the wall including a filter media outlet which is normally closed, and opening means for opening the filter media outlet to allow the filter media to discharge into the lower portion of the tank. The invention also relates to a method of refilling the filter with filter media
Patent CA-2507970-A1 (CA)
Inventor: OMURA TAKESHI
IPC: C22C38/34
Filed: 2003-12-18
Abstract: L'invention concerne une feuille d'acier électromagnétique non-orienté à base de Fe-Cr-Si comprenant entre 2,5 et 10 % en masse de Si, entre 1,5 et 20 % en masse de Cr, 0,006 % en masse ou moins de C, 0,002 % en masse ou moins de N, 0,005 % en masse ou moins de S, 0,005 % en masse ou moins de Ti et 0,005 % en masse ou moins de Nb, éventuellement conjointement avec entre 0,1 et 2 % en masse de Al et Sb ou Sn individuellement ou bien les deux, sous réserve que la somme, dans chaque cas de Sb et de Sn, se situe entre 0,005 et 1 % en masse, l'équilibre s'effectuant avec Fe et des impuretés inévitables. La résistance électrique de l'acier est de 60 µ.OMEGA.cm ou davantage et la quantité de nitrure contenant Cr, situé à l'intérieur de la feuille d'acier, s'élève à 2.500 ou moins par mm?2¿. L'invention permet d'obtenir une feuille d'acier électromagnétique non-orienté qui présente d'excellentes propriétés magnétiques dans la zone haute fréquence, notamment dans la zone de fréquence d'1 kHz ou davantage, ce qui constitue une solution avantageuse apportée au problème posé par le fait que la résistance électrique élevée atteinte avec des teneurs élevées en Si et en Cr n'est pas pleinement exploitée dans la zone de haute fréquence de 10 kHz ou moins.
Patent CA-2508525-A1 (CA)
Title: Detection of channel quality indicator
Inventor: RUDOLF MARIAN
IPC: H04W48/08
Filed: 2003-12-02
Abstract: A method for improving the reliability of a channel quality indicator (CQI) (102, 106 Fig. 3) message in a wireless communications network begins with receipt of the CQI message. The CQI message is then decoded, and a decision metric value for each symbol in the CQI message is computed. A largest decision metric value and a second largest decision metric value for the CQI message are determined. The reliability of the CQI message can be determined by comparing the two largest decision metric values. This method may be applicable to high-speed downlink packet access in time division duplex, frequency division duplex, or other modes of transmission.
Patent CA-2508763-A1 (CA)
Inventor: ISHIDA ISAO
IPC: C12N15/87
Filed: 2002-05-10
Abstract: Disclosed is a human antibody producing mouse, which carries: (a) an unrearranged human antibody heavy chain gene locus, (b) an unrearranged human antibody .kappa. light chain gene locus and (c) an unrearranged human antibody .lambda. light chain gene locus, wherein at least one of (a), (b) and (c) is retained on one or more human derived chromosome fragments and at least one of (a), (b) and (c) is inserted into a mouse chromosome, and further wherein at least both alleles of endogenous heavy chains and both alleles of endogenous .kappa. light chains are inactivated, and the mouse expresses human antibody heavy chain, human antibody .kappa. light chain and human antibody .lambda. light chain in serum of the mouse. The mouse is useful in producing human antibodies.
Patent CA-2509874-A1 (CA)
Title: Circuit for the operation of light sources
Inventor: HAEUSSER-BOEHM HELMUT
IPC: H05B37/02
Filed: 2005-06-14
Abstract: An electronic transformer for halogen incandescent lamps is equipped with a self-commutated half-bridge inverter. The half-bridge inverter contains a start circuit with a start capacitor (C3), which starts commutation of the half-bridge inverter after each mains half-wave by driving a lower half-bridge transistor (T2). The start circuit has to be suppressed while the half-bridge inverter is commutating. This is achieved according to the invention by discharging the start capacitor (C3) when-ever an upper half-bridge transistor is turned on (T1). This is done by an amplifier element (V1), which is driven via a high-pass filter (C4) from the half-bridge midpoint (M).
Patent CA-2510409-A1 (CA)
Inventor: PAUL CORY
IPC: E06B9/42
Filed: 2005-06-03
Abstract: A pull out retractable system, such as a vertical blind, which pulls back on a spring system located in a metal core. The metal core has a twisted spring insert that is connected at both ends, and has twisted tension in the middle to allow the retractable motion after pull out. A safety material is then wrapped around the spring system and is then placed in a casing made of aluminium for strength and support. For ease of movement, a slit is located at one side to allow the material to slide in and out.      The safety material is pulled out and stretched across an area and connected at the other end with hooks and magnets. To release, unhook and the material retracts back into the casing till next use.
Patent CA-2512476-A1 (CA)
Inventor: FUKUSHIMA HIROSHI
IPC: A61K31/401
Filed: 2001-11-09
Abstract: A cynaopyrrolidine derivative and pharmaceutical compositions containing same for inhibiting dipeptidyl peptidase IV to treat conditions such as diabetes mellitus and immune diseases. The derivative is represented by Formula (1):   (see formula 1) wherein R1 is a halogen atom, a hydroxyl group, an alkoxy group having 1 to 5 carbon atoms or an alkyl group having 1 to 5 carbon atoms; R2 is a hydrogen atom, a halogen atom, a hydroxyl group, an alkoxy group having 1 to 5 carbon atoms or an alkyl group having 1 to 5 carbon atoms; or R1 and R2 together form an oxo, a hydroxyimino group, an alkoxyimino group having 1 to 5 carbon atoms or an alkylidene group having 1 to 5 carbon atoms; R3 and R4 are each a hydrogen atom, a halogen atom, a hydroxyl group, an alkoxy group having 1 to 5 carbon atoms or an alkyl group having 1 to 5 carbon atoms;  or R3 and R4 together form an oxo, a hydroxyimino group, an alkoxyimino group having 1 to 5 carbon atoms or an alkylidene group having 1 to 5 carbon atoms;      X is an oxygen atom or a sulfur atom; Y is -CR5R6- wherein R5 and R6 are the same or different, and are each a hydrogen atom, a halogen atom, an optionally substituted alkyl group having 1 to 10 carbon atoms or an optionally substituted alkenyl group having 2 to 10 carbon atoms; or -CR7R8-wherein R7, R8, R9 and R10 are the same or different, and each a hydrogen atom, a halogen atom or an optionally substituted alkyl group having 1 to 10 carbon atoms; or R7 and R9 together with the carbon atom to which they are attached form an optionally substituted cycloalkyl group having 3 to 8 carbon atoms, an optionally substituted cycloalkenyl group having 4 to 8 carbon atoms; an optionally substituted bicycloalkyl group having 5 to 10 carbon atoms, or an optionally substituted bicycloalkenyl group having 5 to 10 carbon atoms; and Z is a hydrogen atom or an optionally substituted alkyl group having 1 to 10 carbon atoms, or Y and Z together with the nitrogen atom to which they are attached form an optionally substituted cyclic amino group having 2 to 10 carbon atoms; or a pharmaceutically acceptable salt thereof.
Patent CA-2513697-A1 (CA)
Inventor: BALES THOMAS O
IPC: A61M25/00
Filed: 2004-02-04
Abstract: L'invention concerne des procédés et dispositifs pour traiter l'intérieur d'un vaisseau sanguin, faisant appel à différents types de cathéters. Elle concerne également des procédés et dispositifs pour l'occlusion d'un vaisseau sanguin; des procédés et dispositifs pour localiser un dispositif d'occlusion; des procédés et dispositifs pour localiser un dispositif de traitement sur le site de branches de vaisseaux sanguins; et des procédés et dispositifs pour distribuer un agent de traitement.
Patent CA-2514548-A1 (CA)
Inventor: FREDRICKSON JENNIFER K
IPC: A61K9/50
Filed: 2004-01-23
Abstract: The present invention is directed to a suspension vehicle for coated drug particles. The coated drug particles are suitable for use in taste masking.  The suspension vehicle disclosed enables the maintenance of coated drug particles with an average particle size of about 50 ~m to about 600 ~m in suspension for an extended period of time, without sedimentation or floating, even after shaking in the presence of air. The suspension vehicle of the present invention makes it possible to produce multidose oral suspensions of coated drugs, from which consistent dosages can be dispensed over time. The dry formulations, methods, and suspension vehicles of the present invention are particularly well suited for the delivery of objectionable tasting drugs, such as linezolid.
Patent CA-2514897-A1 (CA)
Inventor: FUISZ JOSEPH M
IPC: A61K9/70
Filed: 2004-01-30
Abstract: The invention relates to film products containing desired levels of active components and methods of their preparation. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. Desirably, the films may be exposed to temperatures above that at which the active components typically degrade without concern for loss of the desired activity.
Patent CA-2516814-A1 (CA)
Title: Methods of evaluating glycomolecules for enhanced activities
Inventor: SASISEKHARAN RAM
IPC: C08B37/00
Filed: 2004-02-13
Abstract: Methods to evaluate and rapidly produce and identify polysaccharides, and other sugar structures, having enhanced activities, have been developed. The methods include producing a molecule, e.g., a therapeutic molecule, which includes a first, non-saccharide moiety (e.g., a protein, polypeptide, peptide, amino acid or lipid) and a second, saccharide moiety. The method includes: determining the chemical composition and structure of all or a portion of the second, saccharide moiety, and evaluating or screening the molecule, e.g., for a biological activity or other chemical or physical property. In some embodiments, the step of determining the chemical structure and composition of the second moiety includes a comparison of one or more properties of the second moiety with a database, e.g., a database which correlates such one or more properties with structure or function of a ploysaccharide.
Patent CA-2522203-A1 (CA)
Title: Identification of n-alkylglycine trimers for induction of apoptosis
Inventor: CORTES NURIA
IPC: A61K31/337
Filed: 2004-04-08
Abstract: N-alkylglycine trimers with the capacity to arrest the cell cycle in human cancer cells and to induce apoptosis useful for the therapy of cancer.  Combination of said N-alkylglycine trimers with taxol.
Patent CA-2523740-A1 (CA)
Inventor: LEVERVE XAVIER M
IPC: A23L33/00
Filed: 2004-03-22
Abstract: The invention relates to a pharmaceutical composition containing 250 to 2400 millimoles per liter of lactate or lactic acid, 2 to 10 millimoles per liter of potassium cation and optionally 2 to 5 millimoles per liter of calcium cation. The invention also relates to pharmaceutical uses of this composition.  The invention also relates to pharmaceutical uses of a composition having a lactic acid or lactate concentration between 250 to 2400 millimoles per liter.
Patent CA-2524108-A1 (CA)
Inventor: BONNAUD BERNARD
IPC: B60R13/00
Filed: 2005-10-21
Abstract: Une roue motrice est conçue pour pivoter autour d'un premier axe (X-X'), qui, en particulier, est horizontal afin de faire avancer le véhicule, et autour d'un deuxième axe (YY'), qui, en particulier, est vertical afin de diriger le véhicule, alors que le carénage s'étend latéralement vers la proximité de la roue lorsque le véhicule est en marche, de sorte qu'il couvre au moins partiellement un côté extérieur de ladite roue. Le carénage n'est pas lié en rotation à la roue autour du premier axe, ce qui a pour résultat qu'il n'est pas limité à pivoter autour dudit axe pendant la marche avant du véhicule, alors que le carénage est lié en rotation avec ladite roue autour du deuxième axe, de sorte qu'il suive les mouvements de direction de ladite roue.
Patent CA-2526756-A1 (CA)
Inventor: KUMLIN KRISTER
IPC: A01K85/18
Filed: 2004-05-21
Abstract: A lure (1, 28) for use when angling with a fishing rod and line. The lure has a first structural member (2, 29) and a second structural member (3, 30), said structural members enclosing at least one cavity (24, 25, 53, 54), having a volume which is variable by means of a relative movement between the structural members, said relative movement bringing about a change of displacement of the lure.
Patent CA-2526852-A1 (CA)
Title: Use of 2h- [1,3] - oxazino [3,2-a] indole derivatives for the treatment of neuropathic pain
Inventor: POLENZANI LORENZO
IPC: A61P25/02
Filed: 2004-07-08
Abstract: Use of a compound of formula (I), wherein R is H, a linear or branched alkyl chain having from 1 to 12 carbon atoms or an arylalkyl group, and of the acid addition salts thereof with pharmaceutically acceptable organic or inorganic acids, to prepare a pharmaceutical composition active in the treatment of neuropathic pain.
Patent CA-2527937-A1 (CA)
Inventor: VERDIER AMANDINE
IPC: B01D45/12
Filed: 2004-06-03
Abstract: Dispositif de collecte de particules et de micro-organismes présents dans l'air ambiant, comprenant des moyens (14) d'aspiration d'air dans une encein te (10) de faible volume dans laquelle les particules et micro~organismes sont séparés de l'air aspiré par centrifugation, ce dispositif étant portable, autonome et manipulable d'une seule main, par exemple au moyen d'une poignée (16) associée aux moyens d'aspiration d'air.
Patent CA-2528396-A1 (CA)
Title: Patch bag and barrier bag
Inventor: DAWE MATTHEW D
IPC: B65D65/40
Filed: 2005-11-29
Abstract: A patch bag includes a patch having a layer including styrene/butadiene/styrene block copolymer. A bag includes a layer including styrene/butadiene/styrene block copolymer, and a layer including an oxygen barrier.
Patent CA-2530781-A1 (CA)
Inventor: WERNER PETER F
IPC: G07C3/00
Filed: 2005-12-14
Abstract: A motor control centre is provided having an analyst system which is capable of recording data from the monitoring equipment provided therein, and providing a predictive analysis of the data received. The predictive analysis allows the operator to have the ability to schedule routine maintenance to correct a predicted failure of a device to continue operation within a pre-determined set of parameters. Improved operation and maintenance of a controlled system is achieved.
Patent CA-2533019-A1 (CA)
Inventor: AYRE PETER JOSEPH
IPC: A61M1/12
Filed: 2004-06-24
Abstract: An implantable device including a cuff (8) positioned to contact the outer surface of a tubular body (9) carrying blood. At sensor (13) to measures blood pressure is encapsulated within the cuff. The device does not occlude or adversely affect the flow or blood pressure within a patient~s circulatory system. Also disclosed is a system to control an implantable blood pump using a pressure based on a pressure measurement of blood flow at the inlet to the pump.
Patent CA-2533532-A1 (CA)
Title: Footwear having an enclosed and articulated toe
Inventor: FUERST RORY W
IPC: A43B1/14
Filed: 2004-07-22
Abstract: Articles of footwear (100, 200) having an enclosed articulated toe portion, including a molded midsole (14) with an integrally-molded toe cap (20) shaped to receive a foot therein and to enclose the toes of the foot. The toe cap terminates at a position adjacent to the base of the toes of the foot. The articles additionally include an outsole (16) affixed to the bottom of the midsole and an upper which in some embodiments is co-molded with the midsole (14) and toe cap (20).
Patent CA-2534784-A1 (CA)
Inventor: AVERY ROBERT CLARK JR
IPC: A61F13/26
Filed: 2004-08-12
Abstract: A process for making an applicator device capable of housing an insertable element first providing an insertion member having an insertion end and a gripper end. Next, a plunger is provided having a diameter, an insertion end, and a gripper end. A plurality of slits are produced on the insertion end of the plunger. After the insertion end of the plunger is slit, it is deformed to form the locking mechanism. Next, the plunger is inserted the insertion member. In some embodiments, the locking mechanism is arranged for the plunger slideably introduced into the insertion member.
Patent CA-2535675-A1 (CA)
Title: Polyamine-based corrosion inhibitors
Inventor: FORD MICHAEL EDWARD
IPC: C07C211/63
Filed: 2006-02-08
Abstract: Compounds having N-oxide, quaternary ammonium, and/or betaine functionality according to formulas (1) - (4) are effective corrosion inhibitors, suitable for use in any of a variety of applications such as automotive cooling systems, heating boilers, drilling of oil wells, and the handling, transportation and storage of crude petroleum and various petroleum fractions.        See formula I     The groups R1 - R5 may be certain hydrocarbyl groups. In formulas (1) and (3), R3 may also be (CH2)p-COO- in which p is either 1 or 2, and R2 may also be (CH2)p-COO-in formulas (3) and (4). In the compounds of formulas (1) and (2), R2 may also be a polyhydroxyalkyl group of formula (A), shown below.
Patent CA-2536368-A1 (CA)
Title: Expandable sheath tubing
Inventor: WRIGHT JOHN A JR
IPC: A61F2/06
Filed: 2004-08-19
Abstract: An expandable catheter (10) accommodates a medical device that is being removed from a body with a larger diameter than the catheter. The same catheter may be used to reposition a device within the body to an alternative delivery site. A catheter or sheath may be used to deliver a medical device, surgical instrument, or biological sample.
Patent CA-2541814-A1 (CA)
Title: Pharmaceutical compositions comprising malonamide derivatives for decreasing sebum production
Inventor: WADE KIMBERLY JANE
IPC: A61K8/49
Filed: 2004-09-27
Abstract: The present invention is directed to the topical application of the malonamide ACAT inhibitors described by Formula I. Other aspects of the invention are directed to topical formulations of these diamides, their use to treat sebaceous gland disorders and their use to alleviate oily skin.
Patent CA-2542394-A1 (CA)
Inventor: NOMICHI KAORU
IPC: F16J15/10
Filed: 2004-10-14
Abstract: A resin sub-seal member (11) provided with a concave groove (16) is disposed at a region closer to a higher-pressure side region than a rubber main seal member (10) and pressure variation in a gas on a higher-pressure side is inhibited from being transmitted to the main seal member (10). Further, a variation reducing space (13) is formed between the seal members (10) and (11) to be able to reduce the pressure variation when gas leakage in the sub-seal member (11) occurs or the sub-seal member (11) responds with a delay with respect to the pressure variation. Thus, rapid change in the pressure of the gas surrounding the main seal member (10) is inhibited, occurrence of the blistering phenomenon is inhibited, and a high seal ability is achieved. The seal structure is formed by a simple structure including the seal members (10) and (11), and the variation reducing space (13).
Patent CA-2544845-A1 (CA)
Title: Preparation of pharmaceutical salts of [1, 4] - bipiperidine
Inventor: ELSE HOWARD
IPC: A61P11/06
Filed: 2004-11-03
Abstract: The invention provides anhydrous and hydrated forms of sodium salt of N-[ [4-(3, 4-dichlorophenoxy) [1, 4'-bipiperidin] -1'-yl]carbonyl]-4-methyl -benzenesulfonamide and crystalline forms of N- [[4-(3,4-dichlorophenoxy) [1,4' -bipiperidin]- 1' -yl]carbonyl] -4-methyl-benzenesulfonamide; and such compounds are modulators of chemokine (especially CCR3) activity and are especially useful for treating asthma and/or rhinitis.
Patent CA-2545081-A1 (CA)
Title: Safety spinal catheter
Inventor: WILEY CHRISTOPHER
IPC: A61M31/00
Filed: 2004-10-26
Abstract: An apparatus and method to insert a spinal catheter and minimize incidence of post dural puncture headache. The apparatus typically includes a support needle with a non~cutting piercing tip and an exteriorly mounted catheter. The catheter gauge is reduced, while ease of use is increased by the exterior mounting. The catheter may include a kink sleeve that protects against kinking when bent during use. A central stylet may be included to prevent entry of matter into the support needle opening during insertion. Methods using a single stick insertion procedure allow for catheter placement to be determined and adjusted based on physical feedback obtained during the single stick insertion.
Patent CA-2546822-A1 (CA)
Title: Orientated acrylate adhesive materials, method for the production and use thereof
Inventor: ZOELLNER STEPHAN
IPC: C09J133/04
Filed: 2005-01-04
Abstract: The invention relates to an orientated adhesive material and to a method for the production thereof. The adhesive material comprises a UV cross-linked polymer based on acrylate, which consists of at least 50 % by mass of at least one acrylic monomer according to general formula (I), wherein R1 represents hydrogen (H) or a methyl group (CH3) and R2 represents hydrogen (H) or an unbranched or branched, saturated C1 - C30- hydrocarbon radical which is substituted, optionally, by a functional group. The adhesive material in the form of a film which is applied as a melt (hot-melt) has a preferred direction, said direction being characterised in the free film by a back shrinkage of at least 3 % in relation to an initial expansion of the film in the preferred direction. Orientation is produced after polymerisation by a suitable coating method and subsequently frozen by UV cross-linking. The adhesive material has excellent properties as an adhesive layer on single or double-sided adhesive strips.
Patent CA-2547001-A1 (CA)
Title: Agrochemical compositions
Inventor: RAMSAY GUY
IPC: A01N33/04
Filed: 2004-12-06
Abstract: The present invention relates to agrochemical compositions and in particular to aqueous agrochemical compositions containing a water soluble agrochemical active ingredient and an amine adjuvant; preferably triethylenediamine (TEDA) or a salt thereof; or tetramethylethylenediamine (TMEDA) or a salt thereof.
Patent CA-2547950-A1 (CA)
Inventor: FALKVALL THORE
IPC: A61M1/36
Filed: 1993-11-12
Abstract: Methods are disclosed for providing operational instructions to a hemodialysis circuit (10) having a dialysis filter (48) and a capability of operating according to a time-varying parameter such as variable ultrafiltration. According to the methods, entered are a desired time period, a target cumulative value of the parameter, such as target ultrafiltration volume, and a proposed time-varying profile of the parameter that is representable as a plot of coordinates in a region defined by an ordinate of values of the parameter and a time-based abscissa defining a profile cumulative value of the parameter. If the profile cumulative value is not equal to the target cumulative value, then the proposed time-varying profile is changed along the ordinate to make the cumulative values equal. The circuit (10) then operates according to the changed profile to achieve the entered target cumulative value within the time period.
Patent CA-2550398-A1 (CA)
Title: Mir-a-collar
Inventor: GALLAGHER PENNY E
IPC: A61K9/00
Filed: 2006-06-16
Abstract: A none invasive, drug free collar that aids in the motility of warm blooded animals. This collar consists of magnets, copper chain or wire and beads of various compounds. Copper and magnets have been used for centuries to relieve pain and inflammation. The beads are attached to the copper chain. The copper chain ends fasten together with magnets. These magnets insure easy release of collar for safety to the animal but are strong enough to keep the collar secure and in place. The beads are for esthetic appeal and may consists of glass, plastic or semi precious stones including but not limited to onyx, tiger eye, jade or other precious or semi precious stone.